摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Bisprezatide copper | 130120-56-8

中文名称
——
中文别名
——
英文名称
Bisprezatide copper
英文别名
copper;(2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate
Bisprezatide copper化学式
CAS
130120-56-8
化学式
C28H46CuN12O8
mdl
——
分子量
742.3
InChiKey
YINACRBQQGZRRM-XTQNZXNBSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -6.48
  • 重原子数:
    49
  • 可旋转键数:
    20
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    358
  • 氢给体数:
    10
  • 氢受体数:
    14

文献信息

  • Chemical derivatives of GHL-CU
    申请人:PROCYTE CORPORATION
    公开号:EP0288278A2
    公开(公告)日:1988-10-26
    Derivatives of GHL-Cu possessing greater resistance to proteolytic enzyme breakdown are disclosed. These deriva­tives can be tailored to increase their fat solubility, making them more useful in the formation of pharmaceutical creams and gels. Further, the derivatives of the present invention pos­sess significant superoxide dismustase activity, making them, useful for enhancing the wound-healing process in animals.
    本研究公开了具有更强抗蛋白解酶分解能力的 GHL-Cu 衍生物。这些衍生物可以进行定制,以增加其脂溶性,使其更适用于制成药膏和凝胶。此外,本发明的衍生物具有显著的超氧化物歧化酶活性,可用于促进动物伤口愈合。
  • Use of GHL-Cu as antiinflammatory agent
    申请人:PROCYTE CORPORATION
    公开号:EP0577151A1
    公开(公告)日:1994-01-05
    A compound containing glycyl-l-histidyl-l-lysine: copper(II) (GHL-Cu) is disclosed. GHL-Cu functions as a superoxide dismutase which detoxifies tissue-damaging oxygen radicals, but does not evoke an antigenic response. The compound may be used to treat inflammatory conditions in animals and to reduce the traumatic effects in animals occurring subsequent to major tissue damage.
    本研究公开了一种含有甘酰-组酰-赖酸:(II)(GHL-Cu)的化合物。GHL-Cu 具有超氧化物歧化酶的功能,能解毒破坏组织的氧自由基,但不会引起抗原反应。该化合物可用于治疗动物的炎症,并减少动物在重大组织损伤后产生的创伤效应。
  • Methods for the treatment of hyperpigmentation of skin
    申请人:ProCyte Corporation
    公开号:US20030134781A1
    公开(公告)日:2003-07-17
    Methods for treating hyperpigmentation of skin employ topical application of compositions to skin in need thereof, where the compositions comprise at least one peptide copper complex, or at least one peptide copper complex in combination with retinol, at least one retinol derivative, or a mixture thereof. Also disclosed are methods that use such compositions further comprising active agents selected from active drug substances, emollients, sunscreen agents, skin-lightening agents, skin protectants, skin conditioning agents, and humectants.
    治疗皮肤色素沉着的方法是在有需要的皮肤上局部施用组合物,其中组合物包含至少一种肽复合物,或至少一种肽复合物与视黄醇、至少一种视黄醇生物或它们的混合物的组合。还公开了使用这种组合物的方法,其中进一步包含选自活性药物物质、润肤剂、防晒剂、皮肤美白剂、皮肤保护剂、皮肤调理剂和保湿剂的活性剂。
  • Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
    申请人:ProCyte Corporation
    公开号:US20030134780A1
    公开(公告)日:2003-07-17
    Compositions, generally useful for preserving the skin and/or improving its health and appearance, comprise a peptide copper complex and retinol, a retinol derivative, or a mixture thereof. In another embodiment, the disclosed compositions further comprise additives, including emollients, sunscreen agents, skin protectants, skin conditioning agents, and/or humectants. Also disclosed is a method for treating skin to accomplish such preservation and/or improvement thereof, where the method comprises the step of topically applying a disclosed composition to an area of skin in need of such treatment.
    通常用于保护皮肤和/或改善皮肤健康和外观的组合物包括肽复合物和视黄醇视黄醇生物或其混合物。在另一个实施方案中,所公开的组合物进一步包含添加剂,包括润肤剂、防晒剂、皮肤保护剂、皮肤调理剂和/或保湿剂。还公开了一种治疗皮肤的方法,以达到上述保护和/或改善皮肤的目的,其中该方法包括将公开的组合物局部施用到需要治疗的皮肤区域的步骤。
  • Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
    申请人:ProCyte Corporation
    公开号:US20030148927A1
    公开(公告)日:2003-08-07
    Compositions are formed by adding at least one amino acid to an aqueous solution of at least one peptide copper complex, and disclosed methods impart to solutions of peptide copper complexes, chemical stability and resistance to precipitation of the complexes through the addition of at least one of certain amino acids thereto. Also disclosed are compositions comprising at least one peptide copper complex and at least one of certain amino acids, as well as compositions further comprising one or more preservatives to provide thereto resistance to microbial attack and toxicity to microbes. Medical devices, pharmaceuticals and cosmetics comprising such compositions are also disclosed.
    通过向至少一种肽络合物的溶液中添加至少一种氨基酸可形成组合物,所公开的方法通过向肽络合物的溶液中添加至少一种特定氨基酸,可赋予络合物化学稳定性和抗沉淀性。此外,还公开了包含至少一种肽络合物和至少一种特定氨基酸的组合物,以及进一步包含一种或多种防腐剂的组合物,以提供抗微生物侵袭和抗微生物毒性的能力。此外,还公开了包含此类组合物的医疗器械、药品和化妆品。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸